#412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, and the advances reshaping treatment | Siddhartha Mukherjee, M.D., Ph.D.

Cancer research has evolved significantly over the last 15 years, shifting from a focus on simple genetic mutations to a nuanced understanding of inflammatory states and regenerative failure. While hereditary mutations like BRCA1 represent a fraction of cancer risk, many malignancies arise from random mutations compounded by chronic inflammation and metabolic dysregulation, such as hyperinsulinemia. Early detection remains a critical challenge, as current screening methods often lack the precision to distinguish between dormant "sleeper" cells and active tumors. Emerging therapeutic strategies, including immunotherapy and CAR T-cell treatments, offer durable cures for specific blood cancers, while future advancements in AI-driven drug discovery and thymic regeneration promise to address the underlying biology of aging. Ultimately, extending human health span requires a systematic approach to identifying biomarkers that distinguish wellness from the physiological decline associated with age-related diseases.